L
Luis M. Ruilope
Researcher at European University of Madrid
Publications - 891
Citations - 109166
Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive rats: role of nitric oxide.
Rosaura Maeso,Elena Rodrigo,Raquel Muñoz-García,Josefa Navarro-Cid,Luis M. Ruilope,Vicente Lahera,Victoria Cachofeiro +6 more
TL;DR: Angiotensin II seems to participate in the vasoconstriction induced by both endothelin-1 and the thromboxane A2 analogue through the stimulation of AT1 receptors in SHR aortic rings, because losartan inhibited this effect.
Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study.
José M. Morales,E. Rodriguez-Paternina,A. Araque,Amado Andrés,E. Hernandez,Luis M. Ruilope,Jose L. Rodicio +6 more
Journal ArticleDOI
Prevention of microalbuminuria in patients with type 2 diabetes and hypertension.
Jan Menne,Joseph L. Izzo,Sadayoshi Ito,Andrzej Januszewicz,Shigehiro Katayama,Christos Chatzykirkou,Albert Mimran,Ton J. Rabelink,Eberhard Ritz,Luis M. Ruilope,Lars Christian Rump,Giancarlo Viberti,Hermann Haller +12 more
TL;DR: Patients with a better BP reduction are less likely to develop microalbuminuria, and treatment with olmesartan delayed the onset of micro Albuminuria independent of the baseline BP and the degree of BP reduction.
Journal ArticleDOI
Ambulatory blood pressure monitoring in daily clinical practice – the Spanish ABPM Registry experience
Manuel Gorostidi,José R. Banegas,Alejandro de la Sierra,Ernest Vinyoles,Julian Segura,Luis M. Ruilope +5 more
TL;DR: It is thought that a systematic use of ambulatory blood pressure monitoring, and strategies to improve blood pressure control constitute key priorities in hypertension management.
Journal ArticleDOI
Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
Luis M. Ruilope,Julian Segura +1 more
TL;DR: AIIAs such as losartan should perhaps be considered mandatory therapy in patients with diabetic nephropathy and should complement existing management strategies, such as reduced dietary protein intake, strict blood glucose control, and standard antihypertensive therapy.